Rapid testing using the verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 3, 2015, Pages 1588-1595

  Bork, Jacqueline T ^a   Leekha, Surbhi ^a   Heil, Emily L ^a,b   Zhao, LiCheng ^a   Badamas, Rilwan ^c   Johnson, J Kristie ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Department of Pharmacy University of Maryland Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NUCLEIC ACID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASSAY; BACTERIUM ISOLATE; BLOOD CULTURE; FEMALE; GRAM NEGATIVE SEPSIS; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RAPID TEST; SENSITIVITY AND SPECIFICITY; VERIGENE GRAM NEGATIVE BLOOD CULTURE; ANTIBIOTIC RESISTANCE; BACTEREMIA; DRUG EFFECTS; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACIDS;

EID: 84923240974     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04259-14     Document Type: Article

References (22)

1. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant gramnegative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760-766. http://dx.doi.org/10.1128/AAC.49.2.760-766.2005.
2. Nanosphere, Inc. February 2014. Verigene Gram-negative blood culture nucleic acid test (BC-GN) package insert 027-00039-01, Rev B. Nanosphere Inc, Northbrook, IL.
3. Mancini N, Infurnari L, Ghidoli N, Valzano G, Clementi N, Burioni R, Clementi M. 2014. Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures. J Clin Microbiol 52:1242-1245. http://dx.doi.org/10.1128/JCM.00142-14.
4. Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N. 2014. Evaluation of an automated rapid diagnostic assay for detection of gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS One 9:e9406. http://dx.doi.org/10.137/journal.pone.0094064.
5. Sullivan KV, Deburger B, Roundtree SS, Ventrola CA, Blecker-Shelly DL, Mortensen JE. 2014. Pediatric multicenter evaluation of the Verigene Gram-negative blood culture test for rapid detection of inpatient bacteremia involving Gram-negative organisms, extended-spectrum betalactamases, and carbapenemases. J Clin Microbiol 52:2416-2421. http://dx.doi.org/10.1128/JCM.00737-14.
6. Dodémont M, De Mendonca R, Nonhoff C, Roisin S, Denis O. 2014. Performance of Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 52: 3085-3087. http://dx.doi.org/10.1128/JCM.01099-14.
7. Hill JT, Tran KD, Barton KL, Labreche MJ, Sharp SE. 13 August 2014. Evaluation of the Nanosphere-Verigene BC-GN for the direct identification of Gram negative bacilli and antibiotic resistance markers from positive blood cultures and the potential impact for more rapid antibiotic interventions. J Clin Microbiol http://dx.doi.org/10.1128/JCM.01537-14.
8. Kothari A, Morgan M, Haake D. 2014. Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis 59:272-278. http://dx.doi.org/10.1093/cid/ciu292.
9. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 58:154-158. http://dx.doi.org/10.1093/jac/dkl146.
10. Holtzman C, Whitney D, Barlam T, Miller NS. 2011. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 49:1581-1582. http://dx.doi.org/10.1128/JCM.02461-10.
11. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
13. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351-353. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004.
14. Woodford N, Fagan EJ, Ellington MJ. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)- lactamases. J Antimicrob Chemother 57:154-155. http://dx.doi.org/10.1128/JCM.06382-11.
15. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237-1245. http://dx.doi.org/10.1093/cid/cit498.
16. Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:3381-3383. http://dx.doi.org/10.1128/JCM.00751-06.
17. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M. 2012. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 50:127-133. http://dx.doi.org/10.1128/JCM.06169-11.
18. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA. 2012. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the Film Array system. Diagn Microbiol Infect Dis 74:349-355. http://dx.doi.org/10.1016/j.diagmicrobio.2012.08.013.
19. Rosenblueth M, Martinez L, Silva J, Martinez-Romero E. 2004. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst Appl Microbiol 27:27-35. http://dx.doi.org/10.1078/0723-2020-00261.
20. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. 2013. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 57:3012-3020. http://dx.doi.org/10.1128/AAC.02252-12.
21. Tamma PD, Girdwood SC, Gopaul R, Tekle T, Roberts AA, Harris AD, Cosgrove SE, Carroll KC. 2013. The use of cefepime for treating AmpC beta-lactamase-producing Enterobacteriaceae. Clin Infect Dis 57:781-788. http://dx.doi.org/10.1093/cid/cit395.
22. Siedner MJ, Galar A, Guzman-Suarez BB, Kubiak DW, Baghdady N, Ferraro MJ, Hooper DC, O'Brien TF, Marty FM. 2014. Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia. Clin Infect Dis 58:1554-1563. http://dx.doi.org/10.1093/cid/ciu182.